Non classé

Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit

July 18, 2021

Pfizer Inc (PFE.N) has agreed to pay $345 million to resolve claims by consumers who say they overpaid for EpiPens due to anticompetitive practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan. Source: SwissUXNews

Tags: " 1 activist explained to CNN on Monday. Supporters of voter ID regulations have argued they're required to avoid voter fraud. But in their responses